Page last updated: 2024-09-04

mk 767 and bezafibrate

mk 767 has been researched along with bezafibrate in 6 studies

Compound Research Comparison

Studies
(mk 767)
Trials
(mk 767)
Recent Studies (post-2010)
(mk 767)
Studies
(bezafibrate)
Trials
(bezafibrate)
Recent Studies (post-2010) (bezafibrate)
320101,335267324

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM1
Awano, K; Ide, T; Miyachi, H; Murakami, K; Nomura, M; Takahashi, Y; Tanase, T; Tsunoda, M1
Ide, T; Miyachi, H; Murakami, K; Nomura, M; Suzuki, M; Tanase, T; Tsunoda, M; Uchiki, H1
Henke, BR1
Fujita, H; Hirose, H; Kawai, T; Miyashita, K; Ogawa, T; Saruta, T; Seto, Y; Ukeda, K; Yajima, K; Yamada, T; Yamamoto, Y1
Narce, M; Poisson, JP1

Reviews

2 review(s) available for mk 767 and bezafibrate

ArticleYear
The PPARs: from orphan receptors to drug discovery.
    Journal of medicinal chemistry, 2000, Feb-24, Volume: 43, Issue:4

    Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2000
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
    Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17

    Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors

2004

Other Studies

4 other study(ies) available for mk 767 and bezafibrate

ArticleYear
Design, synthesis and evaluation of substituted phenylpropanoic acid derivatives as peroxisome proliferator-activated receptor (PPAR) activators: novel human PPARalpha-selective activators.
    Bioorganic & medicinal chemistry letters, 2002, Jan-07, Volume: 12, Issue:1

    Topics: Animals; COS Cells; Drug Design; Drug Evaluation, Preclinical; Genes, Reporter; Humans; Phenylpropionates; Protein Isoforms; Receptors, Cytoplasmic and Nuclear; Structure-Activity Relationship; Transcription Factors; Transcriptional Activation; Transfection

2002
Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor alpha subtype-selective activators.
    Journal of medicinal chemistry, 2003, Aug-14, Volume: 46, Issue:17

    Topics: Animals; CHO Cells; Cholesterol; Cricetinae; Fatty Acids, Nonesterified; Humans; Male; Models, Molecular; Phenylpropionates; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Stereoisomerism; Structure-Activity Relationship; Transcription Factors; Transcriptional Activation; Transfection

2003
Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice.
    American journal of physiology. Endocrinology and metabolism, 2003, Volume: 284, Issue:5

    Topics: Animals; Bezafibrate; Body Weight; Diabetes Mellitus; Drug Therapy, Combination; Glucose; Glucose Transporter Type 2; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Monosaccharide Transport Proteins; Pancreas; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors

2003
Novel PPARgamma-dependent and independent effects for thiazolidinediones.
    Current opinion in lipidology, 2003, Volume: 14, Issue:6

    Topics: Animals; Bezafibrate; Body Weight; Chromans; Diabetes Mellitus, Type 2; Gene Expression; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Proteins; Mice; Monocytes; Pancreas; Pioglitazone; PPAR alpha; PPAR gamma; Pregnancy Proteins; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Rosiglitazone; Thiazoles; Thiazolidinediones; Thiazolidines; Troglitazone; Tumor Necrosis Factor-alpha

2003